Financings in Brief: SurVivaLink
This article was originally published in The Gray Sheet
Executive Summary
SurVivaLink: Automated external defibrillator firm completes $11.2 mil. private placement of Series A preferred stock. Proceeds will go toward "aggressive global marketing," according to a June 17 release. Lead investors in the placement are Fidelity Ventures Limited and Fidelity Investors, L.P. Other institutional investors include CIBC Wood Gundy Ventures, The Spray Venture Fund, L.P., Wellmark, Inc., and Minnesota Management Partners I Limited. Wessels, Arnold & Henderson served as placement agent for the offering. SurVivaLink canceled plans to go public via an initial offering of 3 mil. shares last year due to poor market conditions, the firm explains ("The Gray Sheet" June 24, 1996, p. 13)...